NCT00097006
- Conditions
- Acquired Immunodeficiency Syndrome, Blood Donors, Blood Transfusion, +28 more
- Locations
-
Not specified
Clinical trial condition
Liver Diseases
Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.
8,419 public trials
1,317 recruiting studies
Liver Diseases trial results
NCT01481649
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Department of Medicine, The University of Hong Kong, Queen Mary Hospital Hong Kong
NCT01749865
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Immunotherapy Guangzhou, Guangdong, China
Completed
Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer
NCT00769106
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT01528735
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1241.25.002 Boehringer Ingelheim Investigational Site Kofu, Yamanashi, Japan
- 1241.25.005 Boehringer Ingelheim Investigational Site Kurashiki, Okayama, Japan
- 1241.25.003 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan
- 1241.25.004 Boehringer Ingelheim Investigational Site Nishinomiya, Hyogo, Japan
NCT00241020
- Conditions
- Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +9 more
- Locations
-
Not specified
NCT02114177
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
- Locations
-
- Dothan, Alabama, United States
- Bakersfield, California, United States
- Chula Vista, California, United States
- Los Angeles, California, United States
NCT00209118
- Conditions
- Behavior, Behavioral Symptoms, Blood-Borne Infections, +12 more
- Locations
-
Not specified
NCT01715779
- Conditions
- Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +12 more
- Locations
-
Not specified
Completed
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
NCT01488487
- Conditions
- Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States